Scott Dreyer sold $2.0M of Collegium Pharmaceutical (COLL)

Executed Mar 3, disclosed Mar 5, 2 days later.

Value, as filed

$2.0M

49,976 sh across 2 lots

Executed

Mar 3

the trade date, as filed

Disclosed

Mar 5

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SD Scott Dreyer EVP & Chief Commercial Officer profile →

Scott Dreyer (EVP & Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in COLL. The largest single filing was $2.0M of COLL (49,976 sh across 2 lots, as filed), executed Mar 3.

The name

COLL COLL COLL · 24 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Scott Dreyer in COLL

COLLSALE COLLEGIUM PHARMACEUTICAL, INC $848K
17,600 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET COLLSALE COLLEGIUM PHARMACEUTICAL, INC $626K
16,389 sh × $38.21
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET COLLSALE COLLEGIUM PHARMACEUTICAL, INC $185K
4,861 sh × $38.03
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET COLLSALE COLLEGIUM PHARMACEUTICAL, INC $567K
18,881 sh × $30.03
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET COLLSALE COLLEGIUM PHARMACEUTICAL, INC $462K
15,387 sh × $30.00
Exec Mar 11 2025
Filed Mar 18 2025 · 5:30 PM ET † COLLSALE COLLEGIUM PHARMACEUTICAL, INC $462K
15,387 sh × $30.00
Exec Mar 6 2025
Filed Mar 13 2025 · 5:30 PM ET †